Follow
Christel Bergström
Title
Cited by
Cited by
Year
50 years of oral lipid-based formulations: provenance, progress and future perspectives
OM Feeney, MF Crum, CL McEvoy, NL Trevaskis, HD Williams, ...
Advanced drug delivery reviews 101, 167-194, 2016
3692016
Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs
P Matsson, JM Pedersen, U Norinder, CAS Bergström, P Artursson
Pharmaceutical research 26, 1816-1831, 2009
3552009
Absorption classification of oral drugs based on molecular surface properties
CAS Bergström, M Strafford, L Lazorova, A Avdeef, K Luthman, ...
Journal of medicinal chemistry 46 (4), 558-570, 2003
3502003
Successful oral delivery of poorly water-soluble drugs both depends on the intraluminal behavior of drugs and of appropriate advanced drug delivery systems
BJ Boyd, CAS Bergström, Z Vinarov, M Kuentz, J Brouwers, P Augustijns, ...
European Journal of Pharmaceutical Sciences 137, 104967, 2019
2872019
Early pharmaceutical profiling to predict oral drug absorption: current status and unmet needs
CAS Bergström, R Holm, SA Jørgensen, SBE Andersson, P Artursson, ...
European Journal of Pharmaceutical Sciences 57, 173-199, 2014
2822014
Prediction of ADMET properties
U Norinder, CAS Bergström
ChemMedChem: Chemistry Enabling Drug Discovery 1 (9), 920-937, 2006
2812006
Accuracy of calculated pH-dependent aqueous drug solubility
CAS Bergström, K Luthman, P Artursson
European journal of pharmaceutical sciences 22 (5), 387-398, 2004
2332004
Experimental and computational screening models for prediction of aqueous drug solubility
CAS Bergström, U Norinder, K Luthman, P Artursson
Pharmaceutical research 19, 182-188, 2002
2252002
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1
G Ahlin, J Karlsson, JM Pedersen, L Gustavsson, R Larsson, P Matsson, ...
Journal of medicinal chemistry 51 (19), 5932-5942, 2008
2162008
Poorly soluble marketed drugs display solvation limited solubility
CAS Bergström, CM Wassvik, K Johansson, I Hubatsch
Journal of medicinal chemistry 50 (23), 5858-5862, 2007
2042007
Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media
JH Fagerberg, O Tsinman, N Sun, K Tsinman, A Avdeef, CAS Bergstrom
Molecular pharmaceutics 7 (5), 1419-1430, 2010
1962010
Computational prediction of drug solubility in water-based systems: Qualitative and quantitative approaches used in the current drug discovery and development setting
CAS Bergström, P Larsson
International journal of pharmaceutics 540 (1-2), 185-193, 2018
1872018
Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11)
JM Pedersen, P Matsson, CAS Bergström, J Hoogstraate, A Norén, ...
toxicological sciences 136 (2), 328-343, 2013
1732013
Computational prediction of formulation strategies for beyond-rule-of-5 compounds
CAS Bergström, WN Charman, CJH Porter
Advanced drug delivery reviews 101, 6-21, 2016
1642016
Contribution of solid-state properties to the aqueous solubility of drugs
CM Wassvik, AG Holmén, CAS Bergström, I Zamora, P Artursson
European journal of pharmaceutical sciences 29 (3-4), 294-305, 2006
1582006
Exploring the role of different drug transport routes in permeability screening
P Matsson, CAS Bergström, N Nagahara, S Tavelin, U Norinder, ...
Journal of medicinal chemistry 48 (2), 604-613, 2005
1572005
The biopharmaceutics classification system (BCS) and the biopharmaceutics drug disposition classification system (BDDCS): beyond guidelines
A Charalabidis, M Sfouni, C Bergström, P Macheras
International journal of pharmaceutics 566, 264-281, 2019
1542019
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2)
JM Pedersen, P Matsson, CAS Bergström, U Norinder, J Hoogstraate, ...
Journal of medicinal chemistry 51 (11), 3275-3287, 2008
1482008
A global drug inhibition pattern for the human ATP-binding cassette transporter breast cancer resistance protein (ABCG2)
P Matsson, G Englund, G Ahlin, CAS Bergström, U Norinder, P Artursson
Journal of Pharmacology and Experimental Therapeutics 323 (1), 19-30, 2007
1472007
Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability
A Alhalaweh, A Alzghoul, D Mahlin, CAS Bergström
International journal of pharmaceutics 495 (1), 312-317, 2015
1292015
The system can't perform the operation now. Try again later.
Articles 1–20